Dr. Angela Wandinger-Ness has been chosen to receive the 2019 STC.UNM Innovation Fellow Award in recognition of her achievements as a leading innovator at the University of New Mexico. Dr. Wandinger-Ness is a Professor in the Department of Pathology, the Victor and Ruby Hansen Surface Endowed Professor in Cancer Cell Biology & Clinical Translation, and the Associate Director for Education, Training & Mentoring at the Comprehensive Cancer Center.
The STC.UNM (STC) Board of Directors presents this special award each year to a university faculty inventor(s) whose body of technologies have made a significant social and economic impact on society and the marketplace. The award will be presented to Dr. Wandinger-Ness at STC’s 2019 Innovation Awards Dinner on April 23, 2019. The annual event also recognizes UNM faculty, staff and students who have received issued U.S. patents and registered U.S. copyrights/trademarks within the past year. Thirteen of the faculty being recognized are UNM CCC research program members. See the full recognition list.
UNM Comprehensive Cancer Center Director & CEO Dr. Cheryl L. Willman commented:
“Angela has conducted outstanding research, leading a team comprised of top investigators at the UNM Comprehensive Cancer Center to discover that an FDA-approved drug has potential to fight ovarian cancer metastasis. She has tremendous leadership capabilities and has developed a pipeline from the high school level through junior faculty level. Angela passionately serves as the Associate Director for Training, Education and Mentoring at the UNM Comprehensive Cancer Center. We couldn’t be more proud of her accomplishments; they will have an impact on ovarian cancer patients and on future scientists.”